Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Fractures: Bone Repair01:27

Fractures: Bone Repair

3.0K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.0K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

5.7K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
5.7K
Gross Anatomy of Bone01:17

Gross Anatomy of Bone

4.9K
The two main features of a long bone are the diaphysis and the epiphysis.
The diaphysis is the tubular shaft that runs between the proximal and distal ends of the bone. The walls of the diaphysis are composed of dense and hard compact bone made of numerous osteons — the functional unit of the compact bone. The hollow region in the diaphysis is called the medullary cavity, which harbors the bone marrow. In infants and children, this marrow cavity is filled with red marrow, whereas in...
4.9K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

904
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
904
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

3.1K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to the Letter by Zhang "The hidden variable in a 'neutral' upgrade: why parameter re-tuning and perceived reliability matter after G6 → G7 in Control-IQ".

Therapeutic advances in endocrinology and metabolism·2026
Same author

Sex differences in cardiovascular risk factors and cardiovascular disease in patients with hyperprolactinemia: a multicenter cross-sectional study.

Endocrine·2026
Same author

Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology.

Therapeutic advances in endocrinology and metabolism·2026
Same author

Sex- and Age-Specific Metabolic Outcomes of Prolactin Normalisation in Hyperprolactinaemia.

Clinical endocrinology·2026
Same author

Usage of lipid-lowering therapies in patients at high and very high cardiovascular risk from Spain: one-year follow-up of the Spanish subpopulation from the European SANTORINI study.

Revista clinica espanola·2025
Same author

Therapeutic Management and Long-Term Outcome of Hyperthyroidism in Patients with Antithyroid-Induced Agranulocytosis: A Retrospective, Multicenter Study.

Journal of clinical medicine·2023

Related Experiment Video

Updated: Jun 13, 2025

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

18.3K

Osteogenesis imperfecta type V: About a clinical case.

María Fernanda Reinoso Gomezcoello1, Isabel Pavón de Paz1, Cristina Navea Aguilera1

  • 1Servicio de Endocrinología y Nutrición, Hospital Universitario de Getafe, Getafe, Madrid, Spain.

Endocrinologia, Diabetes Y Nutricion
|May 16, 2025
PubMed
Summary

Osteogenesis imperfecta (OI) is a rare bone disorder causing fragile bones and fractures. A new case highlights IFITM5 gene mutations as a cause of OI type V, featuring distinct bone abnormalities.

Keywords:
BifosfonatosBisphosphonatesBone mineral densityDensidad mineral óseaDisplasia esqueléticaIFITM5MutaciónMutationOsteogenesis imperfectaOsteogénesis imperfectaSkeletal dysplasia

More Related Videos

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.1K
A Simple Critical-sized Femoral Defect Model in Mice
09:41

A Simple Critical-sized Femoral Defect Model in Mice

Published on: March 15, 2015

15.1K

Related Experiment Videos

Last Updated: Jun 13, 2025

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects
07:35

Creating Rigidly Stabilized Fractures for Assessing Intramembranous Ossification, Distraction Osteogenesis, or Healing of Critical Sized Defects

Published on: April 11, 2012

18.3K
Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
07:12

Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model

Published on: September 28, 2017

8.1K
A Simple Critical-sized Femoral Defect Model in Mice
09:41

A Simple Critical-sized Femoral Defect Model in Mice

Published on: March 15, 2015

15.1K

Area of Science:

  • Genetics
  • Orthopedics
  • Rare Diseases

Background:

  • Osteogenesis imperfecta (OI) is a rare inherited connective tissue disorder characterized by bone fragility and recurrent fractures.
  • Common OI types (I-IV) involve COL1A1 and COL1A2 genes, but new genetic causes are continually being discovered.
  • OI type V, linked to IFITM5 gene mutations, presents unique clinical features.

Purpose of the Study:

  • To present a case study of a patient with a de novo mutation in the IFITM5 gene.
  • To further elucidate the genetic basis and clinical manifestations of Osteogenesis Imperfecta type V.

Main Methods:

  • Genetic analysis to identify mutations in the IFITM5 gene.
  • Clinical evaluation of patient's bone fragility, fracture history, and characteristic OI type V features.
  • Review of existing literature on IFITM5 mutations and Osteogenesis Imperfecta type V.

Main Results:

  • Identification of a de novo mutation in the IFITM5 gene in the presented patient.
  • The patient exhibited hallmark features of OI type V, including hypertrophic callus, interosseous membrane calcification, and hyperdense metaphyseal bands.
  • This case reinforces the role of IFITM5 in the pathogenesis of Osteogenesis Imperfecta type V.

Conclusions:

  • The IFITM5 gene is a significant cause of Osteogenesis Imperfecta type V.
  • Genetic testing for IFITM5 mutations is crucial for diagnosing OI type V.
  • Understanding these mutations aids in managing and potentially treating this rare bone disorder.